Posted by Michael Wonder on 07 Dec 2024
Veozah (fezolinetant film coated tablets) receives Health Canada approval as first and only non-hormonal treatment for vasomotor symptoms associated with menopause
3 December 2024 - New treatment option helps fill unmet need for women experiencing hot flashes and night sweats associated with menopause.
Today, Astellas Pharma Canada proud to announce the Health Canada approval of Veozah (fezolinetant film coated tablets), the first and only non-hormonal treatment indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause.
